Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries

BRIT J SURG. 2024;111(1):.

Decreased mebrofenin uptake in patients with non-colorectal liver tumors requiring liver volume augmentation-a single-center analysis
Fard-Aghaie M, Stern L, Ghadban T, Apostolova I, Lehnert W, Klutmann S, Hackert T, Izbicki J, Li J, von Kroge P, Heumann A
LANGENBECK ARCH SURG. 2024;409(1):92.

Safety and performance of a synthetic sealant patch aimed to prevent postoperative pancreatic fistula after distal pancreatectomy (SHIELDS) - Prospective international multicenter phase II study
Goetz M, Heumann A, Bassi C, Landoni L, Khatib-Chahidi K, Ghadimi M, von Heessen M, Berrevoet F, Gryspeerdt F, Besselink M, van Bodegraven E, Adham M, Pratschke J, Schöning W, Izbicki J, Bockhorn M
HPB. 2024;26(7):903-910.

Robotische Pankreatoduodenektomie: Variationen der Pankreasanastomose in modifizierter Blumgart-Technik
Seeger P, Distler M, Thomaschewski M, Zimmermann M, Heumann A, Uzunoglu F, Grützmann R, Weber G, Brunner M, Kersting S, Hackert T, Keck T, Nickel F
ZBL CHIR. 2024;149(3):226-230.

IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction
Shiri A, Zhang T, Bedke T, Zazara D, Zhao L, Lücke J, Sabihi M, Fazio A, Zhang S, Tauriello D, Batlle E, Steglich B, Kempski J, Agalioti T, Nawrocki M, Xu Y, Riecken K, Liebold I, Brockmann L, Konczalla L, Bosurgi L, Mercanoglu B, Seeger P, Küsters N, Lykoudis P, Heumann A, Arck P, Fehse B, Busch P, Grotelüschen R, Mann O, Izbicki J, Hackert T, Flavell R, Gagliani N, Giannou A, Huber S
J HEPATOL. 2024;80(4):634-644.

Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery
Stern L, Schuette M, Goetz M, Nitschke C, Bardenhagen J, Scognamiglio P, Stüben B, Calavrezos L, Amin T, Heumann A, Lohse A, de Heer G, Izbicki J, Uzunoglu F
HPB. 2024;26(1):117-124.

Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22
Giannou A, Kempski J, Shiri A, Lücke J, Zhang T, Zhao L, Zazara D, Cortesi F, Riecken K, Amezcua Vesely M, Low J, Xu H, Kaffe E, Garcia-Perez L, Agalioti T, Yamada Y, Jungraithmayr W, Zigmond E, Karstens K, Steglich B, Wagner J, Konczalla L, Carambia A, Schulze K, von Felden J, May P, Briukhovetska D, Bedke T, Brockmann L, Starzonek S, Lange T, Koch C, Riethdorf S, Pelczar P, Böttcher M, Sabihi M, Huber F, Reeh M, Grass J, Wahib R, Seese H, Stüben B, Fard-Aghaie M, Duprée A, Scognamiglio P, Plitzko G, Meiners J, Soukou S, Wittek A, Manthey C, Maroulis I, Arck P, Perez D, Gao B, Zarogiannis S, Strowig T, Pasqualini R, Arap W, Gosálvez J, Kobold S, Prinz I, Guse A, Tachezy M, Ghadban T, Heumann A, Li J, Melling N, Mann O, Izbicki J, Pantel K, Schumacher U, Lohse A, Flavell R, Gagliani N, Huber S
IMMUNITY. 2023;56(1):125-142.e12.

IL-22BP controls the progression of liver metastasis in colorectal cancer
Giannou A, Kempski J, Zhang T, Lücke J, Shiri A, Zazara D, Belios I, Machicote A, Seeger P, Agalioti T, Tintelnot J, Sagebiel A, Tomczak M, Bauditz L, Bedke T, Kocheise L, Mercanoglu B, Fard-Aghaie M, Giorgakis E, Lykoudis P, Pikouli A, Grass J, Wahib R, Bardenhagen J, Brunswig B, Heumann A, Ghadban T, Duprée A, Tachezy M, Melling N, Arck P, Stringa P, Gentilini M, Gondolesi G, Nakano R, Thomson A, Perez D, Li J, Mann O, Izbicki J, Gagliani N, Maroulis I, Huber S
FRONT ONCOL. 2023;13:1170502.

EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
Kocheise L, Schoenlein M, Behrends B, Joerg V, Casar C, Fründt T, Renné T, Heumann A, Li J, Huber S, Lohse A, Pantel K, Riethdorf S, Wege H, Schulze K, von Felden J
SCI REP-UK. 2023;13(1):20827.

Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma
Nitschke C, Markmann B, Walter P, Badbaran A, Tölle M, Kropidlowski J, Belloum Y, Goetz M, Bardenhagen J, Stern L, Tintelnot J, Schönlein M, Sinn M, van der Leest P, Simon R, Heumann A, Izbicki J, Pantel K, Wikman H, Uzunoglu F
CLIN CHEM. 2023;69(3):295-307.

Pathogenicity of Human anti-PLA2R1 Antibodies in Minipigs: A Pilot Study
Reinhard L, Wiech T, Reitmeier A, Lassé M, Machalitza M, Heumann A, Ferru N, Loreth D, Schröder M, Hutzfeldt A, Stahl F, Peine S, Gröne H, Meyer-Schwesinger C, Rinschen M, Stahl R, Hoxha E
J AM SOC NEPHROL. 2023;34(3):369-373.

Generating Patient-Derived HCC Cell Lines Suitable for Predictive In Vitro and In Vivo Drug Screening by Orthotopic Transplantation
Staffeldt L, Mattert G, Riecken K, Rövenstrunk G, Volkmar A, Heumann A, Moustafa M, Jücker M, Fehse B, Schumacher U, Lüth S, Kah J
CELLS-BASEL. 2023;13(1):.

Effective sealing of biliary and pancreatic fistulas with a novel biodegradable polyurethane-based tissue sealant patch
Bahar A, Goetz M, Uzunoglu F, Güngör C, Reeh M, Izbicki J, Bockhorn M, Heumann A
HPB. 2022;24(5):624-634.

Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma
Fründt T, von Felden J, Krause J, Heumann A, Li J, Riethdorf S, Pantel K, Huber S, Lohse A, Wege H, Schulze K
FRONT ONCOL. 2022;12:.

A Critical Role of the IL-22-IL-22 Binding Protein Axis in Hepatocellular Carcinoma
Giannou A, Lücke J, Kleinschmidt D, Shiri A, Steglich B, Nawrocki M, Zhang T, Zazara D, Kempski J, Zhao L, Giannou O, Agalioti T, Brockmann L, Bertram F, Sabihi M, Böttcher M, Ewald F, Schulze K, von Felden J, Machicote A, Maroulis I, Arck P, Graß J, Mercanoglu B, Reeh M, Wolter S, Tachezy M, Seese H, Theodorakopoulou M, Lykoudis P, Heumann A, Uzunoglu F, Ghadban T, Mann O, Izbicki J, Li J, Duprée A, Melling N, Gagliani N, Huber S
CANCERS. 2022;14(24):.

Liver surgery-specific complications are an independent factor influencing long-term survival following major hepatectomy
Kemper M, Heumann A, Bibiza-Freiwald E, Stüben B, Izbicki J, Li J
HPB. 2021;23(10):1496-1505.

Early Detection of Hepatocellular Carcinoma Since the Introduction of the German Clinical Practice Guideline in 2013
Schulze K, Felden J, Fründt T, Krause J, Werner T, Casar C, Jung C, Ittrich H, Sterneck M, Li J, Heumann A, Fischer L, Adam G, Lohse A, Wege H
DTSCH ARZTEBL INT. 2021;118(31-32):540-541.

Advanced Robotic Surgery: Liver, Pancreas, and Esophagus - The State of the Art?
Scognamiglio P, Stüben B, Heumann A, Li J, Izbicki J, Perez D, Reeh M
VISC MED. 2021;37(6):505-510.

Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype
Krause J, von Felden J, Casar C, Fründt T, Galaski J, Schmidt C, Jung C, Ittrich H, Weidemann S, Krech T, Heumann A, Li J, Fischer L, Sauter G, Lohse A, Wege H, Schulze K
BMC CANCER. 2020;20(1):1130.

ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study
Li J, Moustafa M, Linecker M, Lurje G, Capobianco I, Baumgart J, Ratti F, Rauchfuss F, Balci D, Fernandes E, Montalti R, Robles-Campos R, Bjornsson B, Topp S, Fronek J, Liu C, Wahba R, Bruns C, Brunner S, Schlitt H, Heumann A, Stüben B, Izbicki J, Bednarsch J, Gringeri E, Fasolo E, Rolinger J, Kristek J, Hernandez-Alejandro R, Schnitzbauer A, Nuessler N, Schön M, Voskanyan S, Petrou A, Hahn O, Soejima Y, Vicente E, Castro-Benitez C, Adam R, Tomassini F, Troisi R, Kantas A, Oldhafer K, Ardiles V, de Santibanes E, Malago M, Clavien P, Vivarelli M, Settmacher U, Aldrighetti L, Neumann U, Petrowsky H, Cillo U, Lang H, Nadalin S
ANN SURG ONCOL. 2020;27(5):1372-1384.

ASO Author Reflections: Optimizing the Oncological Outcome for Locally Advanced Intrahepatic Cholangiocarcinoma
Li J, Moustafa M, Meiners J, Stüben O, Izbicki J, Heumann A
ANN SURG ONCOL. 2020;27(5):1385-1386.

Ectopic Expression of Hematopoietic SHIP1 in Human Colorectal Cancer
Schaks M, Allgoewer K, Nelson N, Ehm P, Heumann A, Ewald F, Schumacher U, Simon R, Sauter G, Jücker M
BIOMEDICINES. 2020;8(7):.

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer
Büscheck F, Zub M, Heumann A, Hube-Magg C, Simon R, Lang D, Höflmayer D, Neubauer E, Jacobsen F, Hinsch A, Luebke A, Tsourlakis M, Sauter G, Huland H, Graefen M, Haese A, Heinzer H, Schlomm T, Clauditz T, Burandt E, Wilczak W, Steurer S, Minner S
TUMOR BIOL. 2019;41(7):1010428318824815.

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy
Minner S, Hager D, Steurer S, Höflmayer D, Tsourlakis M, Möller-Koop C, Clauditz T, Hube-Magg C, Luebke A, Simon R, Sauter G, Göbel C, Weidemann S, Lebok P, Dum D, Fraune C, Izbicki J, Burandt E, Schlomm T, Huland H, Heinzer H, Haese A, Graefen M, Heumann A
NEOPLASIA. 2019;21(9):872-881.

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
Steurer S, Hager B, Büscheck F, Höflmayer D, Tsourlakis M, Minner S, Clauditz T, Hube-Magg C, Luebke A, Simon R, Izbicki J, Burandt E, Sauter G, Fraune C, Weidemann S, Schlomm T, Heinzer H, Haese A, Graefen M, Huland H, Heumann A
AGING-US. 2019;11(18):7859-7879.

Successful Use of the Recanalized Remnant Umbilical Vein as a Patch Graft for Venous Reconstruction in Abdominal Surgery
Stüben B, Heumann A, Stürznickel J, Izbicki J, Li J
J GASTROINTEST SURG. 2019;23(6):1227-1231.

Letter to Editor Reply to: "Centralization of Pancreatic Surgery in Europe: an Update"
Uzunoglu F, Heumann A, Polonski A, Izbicki J
J GASTROINTEST SURG. 2019;23(11):2324-2325.

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
Weidemann S, Sauer C, Luebke A, Möller-Koop C, Steurer S, Hube-Magg C, Büscheck F, Höflmayer D, Tsourlakis M, Clauditz T, Simon R, Sauter G, Göbel C, Lebok P, Dum D, Fraune C, Kind S, Minner S, Izbicki J, Schlomm T, Huland H, Heinzer H, Burandt E, Haese A, Graefen M, Heumann A
BMC CANCER. 2019;19(1):944.

Minimally invasive surgery for colorectal cancer remains underutilized in Germany despite its nationwide application over the last decade
Ghadban T, Reeh M, Bockhorn M, Heumann A, Grotelueschen R, Bachmann K, Izbicki J, Perez D
SCI REP-UK. 2018;8(1):15146.

FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas
Grupp K, Uzunoglu F, Melling N, Hofmann B, El Gammal A, Grotelüschen R, Heumann A, Bellon E, Reeh M, Wolters-Eisfeld G, Ghabdan T, Nentwich M, Bachmann K, Bockhorn M, Bogoevski D, Izbicki J, Kutup A
SCI REP-UK. 2018;8(1):17370.

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
Heinrich M, Göbel C, Kluth M, Bernreuther C, Sauer C, Schroeder C, Möller-Koop C, Hube-Magg C, Lebok P, Burandt E, Sauter G, Simon R, Huland H, Graefen M, Heinzer H, Schlomm T, Heumann A
BMC CANCER. 2018;18(1):612.

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
Heumann A, Heinemann N, Hube-Magg C, Lang D, Grupp K, Kluth M, Minner S, Möller-Koop C, Graefen M, Heinzer H, Tsourlakis M, Wilczak W, Wittmer C, Jacobsen F, Huland H, Simon R, Schlomm T, Sauter G, Steurer S, Lebok P, Hinsch A
BMC CANCER. 2018;18(1):37.

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Heumann A, Kaya Ö, Burdelski C, Hube-Magg C, Kluth M, Lang D, Simon R, Beyer B, Thederan I, Sauter G, Izbicki J, Luebke A, Hinsch A, Jacobsen F, Wittmer C, Büscheck F, Höflmayer D, Minner S, Tsourlakis M, Schlomm T, Wilczak W
SCI REP-UK. 2018;8(1):12821.

Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer
Neubauer E, Latif M, Krause J, Heumann A, Armbrust M, Luehr C, Fraune C, Hube-Magg C, Kluth M, Möller-Koop C, Sauter G, Simon R, Beyer B, Pompe R, Thederan I, Schlomm T, Büscheck F
EXP MOL PATHOL. 2018;105(1):50-56.

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers
Burdelski C, Fitzner M, Hube-Magg C, Kluth M, Heumann A, Simon R, Krech T, Clauditz T, Büscheck F, Steurer S, Wittmer C, Hinsch A, Luebke A, Jacobsen F, Minner S, Tsourlakis M, Beyer B, Steuber T, Thederan I, Sauter G, Izbicki J, Schlomm T, Wilczak W
NEOPLASIA. 2017;19(4):279-287.

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Heumann A, Kaya Ö, Burdelski C, Hube-Magg C, Kluth M, Lang D, Simon R, Beyer B, Thederan I, Sauter G, Izbicki J, Luebke A, Hinsch A, Jacobsen F, Wittmer C, Büscheck F, Höflmayer D, Minner S, Tsourlakis M, Schlomm T, Wilczak W
SCI REP-UK. 2017;7(1):2056.

Erweiterte Pankreasresektion
Heumann A, Perez D, Izbicki J
2017. Expertise Pankreas. Izbicki J, Perez D (Hrsg.). 1. Aufl. Georg Thieme Verlag KG, 44-51.

Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion
Juhnke M, Heumann A, Chirico V, Höflmayer D, Menz A, Hinsch A, Hube-Magg C, Kluth M, Lang D, Möller-Koop C, Sauter G, Simon R, Beyer B, Pompe R, Thederan I, Schlomm T, Luebke A
MOL CARCINOGEN. 2017;56(9):2135-2145.

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
Lotan T, Heumann A, Rico S, Hicks J, Lecksell K, Koop C, Sauter G, Schlomm T, Simon R
ONCOTARGET. 2017;8(39):65566-65576.

CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.
Nienstedt J, Gröbe A, Lebok P, Büscheck F, Clauditz T, Simon R, Heumann A, Sauter G, Möbius C, Münscher A, Knecht R, Blessmann M, Heiland M, Pflug C, kiehn s
CLIN ORAL INVEST. 2017;21(5):1503-1508.

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer
Burdelski C, Dieckmann T, Heumann A, Hube-Magg C, Kluth M, Beyer B, Steuber T, Pompe R, Graefen M, Simon R, Minner S, Tsourlakis M, Koop C, Izbicki J, Sauter G, Krech T, Schlomm T, Wilczak W, Lebok P
TUMOR BIOL. 2016;37(9):12655-12663.

How we do it: double in situ split for staged mesohepatectomy in patients with advanced gall bladder cancer and marginal future liver remnant
Tsui T, Heumann A, Vashist Y, Izbicki J
LANGENBECK ARCH SURG. 2016;401(4):565-71.

Appendicitis: Risk Factors, Management Strategies and Clinical Implications.: State-of-the-Art Imaging in Patients with Suspected Acute Appendicitis.
Tahir E, Avanesov M, Heumann A, Yamamura J, Karul M
2014.

The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer.
Uzunoglu F, Heumann A, Musici S, Kutup A, König A, Roch N, Thomssen A, Dohrmann T, Tsui T, Mann O, Izbicki J, Vashist Y
LUNG CANCER. 2013;79(2):151-155.

Letzte Aktualisierung aus dem FIS: 21.11.2024 - 23:37 Uhr